NO995513L - N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- - Google Patents

N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-

Info

Publication number
NO995513L
NO995513L NO995513A NO995513A NO995513L NO 995513 L NO995513 L NO 995513L NO 995513 A NO995513 A NO 995513A NO 995513 A NO995513 A NO 995513A NO 995513 L NO995513 L NO 995513L
Authority
NO
Norway
Prior art keywords
indolecarboxamides
cck
triazolyl
Prior art date
Application number
NO995513A
Other languages
English (en)
Norwegian (no)
Other versions
NO995513D0 (no
Inventor
Eric Bignon
Jean Pierre Bras
Paul De Cointet
Pierre Despeyroux
Daniel Frehel
Danielle Gully
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995513D0 publication Critical patent/NO995513D0/no
Publication of NO995513L publication Critical patent/NO995513L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO995513A 1997-05-13 1999-11-11 N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK- NO995513L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1998/000905 WO1998051686A1 (fr) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a

Publications (2)

Publication Number Publication Date
NO995513D0 NO995513D0 (no) 1999-11-11
NO995513L true NO995513L (no) 2000-01-12

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995513A NO995513L (no) 1997-05-13 1999-11-11 N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-

Country Status (35)

Country Link
EP (1) EP0984960B1 (zh)
JP (1) JP2001524980A (zh)
KR (1) KR20010012541A (zh)
CN (1) CN1263528A (zh)
AR (1) AR011729A1 (zh)
AT (1) ATE232207T1 (zh)
AU (1) AU725530B2 (zh)
BR (1) BR9811465A (zh)
CA (1) CA2289573A1 (zh)
CO (1) CO4940485A1 (zh)
CZ (1) CZ289484B6 (zh)
DE (1) DE69811223T2 (zh)
DK (1) DK0984960T3 (zh)
DZ (1) DZ2486A1 (zh)
EE (1) EE9900524A (zh)
ES (1) ES2190081T3 (zh)
FR (1) FR2763337B1 (zh)
GT (1) GT199800068A (zh)
HR (1) HRP980258B1 (zh)
HU (1) HUP0002763A3 (zh)
ID (1) ID22911A (zh)
IL (1) IL132903A0 (zh)
IS (1) IS5235A (zh)
NO (1) NO995513L (zh)
NZ (1) NZ500637A (zh)
PL (1) PL336772A1 (zh)
RU (1) RU2175323C2 (zh)
SI (1) SI0984960T1 (zh)
SK (1) SK154299A3 (zh)
TR (1) TR199902795T2 (zh)
TW (1) TW396155B (zh)
UY (1) UY24997A1 (zh)
WO (1) WO1998051686A1 (zh)
YU (1) YU57999A (zh)
ZA (1) ZA983997B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
AU2002226330A1 (en) * 2000-10-26 2002-05-06 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
ATE528006T1 (de) * 2007-01-26 2011-10-15 Merck Sharp & Dohme Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren
WO2010007046A2 (en) * 2008-07-15 2010-01-21 Novartis Ag Organic compounds
US8580831B2 (en) * 2009-06-09 2013-11-12 Actelion Pharmaceuticals Ltd. Fluorinated aminotriazole derivatives
EP2490659B1 (de) * 2009-10-22 2017-03-01 Henkel AG & Co. KGaA Mittel zur temporären verformung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein chitosan
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
MX2022004142A (es) 2019-10-07 2022-09-21 Kallyope Inc Agonistas de gpr119.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
IL132903A0 (en) 2001-03-19
AR011729A1 (es) 2000-08-30
TW396155B (en) 2000-07-01
ID22911A (id) 1999-12-16
FR2763337A1 (fr) 1998-11-20
CN1263528A (zh) 2000-08-16
NO995513D0 (no) 1999-11-11
SI0984960T1 (en) 2003-06-30
FR2763337B1 (fr) 1999-08-20
UY24997A1 (es) 2000-10-31
EP0984960B1 (fr) 2003-02-05
YU57999A (sh) 2002-06-19
DZ2486A1 (fr) 2003-02-01
IS5235A (is) 1999-10-29
DK0984960T3 (da) 2003-05-26
EP0984960A1 (fr) 2000-03-15
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
NZ500637A (en) 2000-11-24
DE69811223T2 (de) 2003-11-27
BR9811465A (pt) 2000-09-12
HUP0002763A3 (en) 2002-05-28
HRP980258B1 (en) 2002-08-31
RU2175323C2 (ru) 2001-10-27
PL336772A1 (en) 2000-07-17
KR20010012541A (ko) 2001-02-15
AU725530B2 (en) 2000-10-12
GT199800068A (es) 1999-11-11
EE9900524A (et) 2000-06-15
ZA983997B (en) 1999-11-12
HRP980258A2 (en) 1999-02-28
CO4940485A1 (es) 2000-07-24
JP2001524980A (ja) 2001-12-04
ATE232207T1 (de) 2003-02-15
WO1998051686A1 (fr) 1998-11-19
SK154299A3 (en) 2000-05-16
CZ289484B6 (cs) 2002-01-16
CZ400699A3 (cs) 2000-02-16
DE69811223D1 (de) 2003-03-13
ES2190081T3 (es) 2003-07-16
TR199902795T2 (xx) 2000-02-21
HUP0002763A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
NO972983D0 (no) Sulfonamider og deres anvendelse
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
DK0958292T3 (da) 4-3(3-heterocyclyl-1-benzoyl)pyrazoler og deres anvendelse som herbicider
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
DE69731238D1 (de) Aufblasbarer hemostat
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
ATE271544T1 (de) 2-amino-6-(2-substituierte-4-phenoxy)- substituierte-pyridine
NO994510L (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO993467D0 (no) Granuler som innbefatter klavulanat og en eller flere eksipienter
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DK0764157T3 (da) Benzopyraner og deres anvendelse som terapeutiske midler
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
NO20003142D0 (no) Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application